Education
About Us
Working with TipRanks
Follow Us
Jupiter Life Line Hospitals Ltd. (IN:JLHL)
:JLHL
JLHL Stock Chart & Stats
₹1542.60
₹35.65(2.30%)
At close: 4:00 PM EST
₹1542.60
₹35.65(2.30%)
Day’s Range― - ―
52-Week Range₹1,199.25 - ₹1,759.00
Previous CloseN/A
Volume62.45K
Average Volume (3M)947.00
Market Cap
₹81.08B
Enterprise Value₹83.22B
Total Cash (Recent Filing)₹6.03B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)43.0
Beta0.24
Next Earnings
May 08, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.14%
Share Statistics
EPS (TTM)7.00
Shares Outstanding65,566,025
10 Day Avg. Volume721
30 Day Avg. Volume947
Financial Highlights & Ratios
PEG Ratio14.64
Price to Book (P/B)7.55
Price to Sales (P/S)8.12
P/FCF Ratio-151.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained top-line growth indicates expanding patient volumes and service mix in a capital-intensive hospital business. Durable revenue expansion supports higher capacity utilization, improves payor negotiating leverage, and provides a recurring base to fund reinvestment and network expansion over the next several quarters.
Improving Margins And Operational EfficiencyRising gross and net margins alongside strong EBIT/EBITDA margins point to persistent operational improvements and cost discipline. Sustainable margin expansion boosts internal cash generation, enhances resilience to input-cost inflation, and enables reinvestment into specialty services that drive long-term competitive differentiation.
Healthy Balance Sheet And Manageable LeverageA conservative debt profile and robust ROE provide financial flexibility for capex, facility upgrades, or selective M&A without over-reliance on volatile financing. Stable equity ratios reduce refinancing risk and support multi-quarter strategic investments in tertiary/quaternary care capabilities.
Bears Say
Negative Free Cash Flow GrowthDeclining free cash flow growth constrains the company’s ability to self-fund capital-intensive hospital expansions and equipment refresh cycles. Over several months this may force increased external financing, pressure liquidity cushions, and limit capacity to accelerate strategic investments or return cash to shareholders.
EPS ContractionA negative EPS growth rate despite revenue gains signals per-share profitability pressure, potentially from dilution, non-operating items, or rising costs. Persisting EPS contraction can reduce investor confidence, limit equity-based financing appeal, and constrain management’s ability to signal long-term profit sustainability.
Limited Forward Transparency (no Guidance)Absence of guidance and limited earnings-call disclosure reduces forward visibility into management’s strategic priorities and expected operational cadence. Over a multi-month horizon this hampers analyst forecasting, makes capital allocation harder to assess, and can weaken stakeholder confidence in execution plans.
Jupiter Life Line Hospitals Ltd. News
JLHL FAQ
What was Jupiter Life Line Hospitals Ltd.’s price range in the past 12 months?
Jupiter Life Line Hospitals Ltd. lowest stock price was ₹1199.25 and its highest was ₹1759.00 in the past 12 months.
What is Jupiter Life Line Hospitals Ltd.’s market cap?
Jupiter Life Line Hospitals Ltd.’s market cap is ₹81.08B.
When is Jupiter Life Line Hospitals Ltd.’s upcoming earnings report date?
Jupiter Life Line Hospitals Ltd.’s upcoming earnings report date is May 08, 2026 which is in 73 days.
How were Jupiter Life Line Hospitals Ltd.’s earnings last quarter?
Jupiter Life Line Hospitals Ltd. released its earnings results on Jan 30, 2026. The company reported ₹7 earnings per share for the quarter, beating the consensus estimate of N/A by ₹7.
Is Jupiter Life Line Hospitals Ltd. overvalued?
According to Wall Street analysts Jupiter Life Line Hospitals Ltd.’s price is currently Overvalued.
Does Jupiter Life Line Hospitals Ltd. pay dividends?
Jupiter Life Line Hospitals Ltd. pays a Notavailable dividend of ₹1 which represents an annual dividend yield of 0.14%. See more information on Jupiter Life Line Hospitals Ltd. dividends here
What is Jupiter Life Line Hospitals Ltd.’s EPS estimate?
Jupiter Life Line Hospitals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jupiter Life Line Hospitals Ltd. have?
Jupiter Life Line Hospitals Ltd. has 65,566,025 shares outstanding.
What happened to Jupiter Life Line Hospitals Ltd.’s price movement after its last earnings report?
Jupiter Life Line Hospitals Ltd. reported an EPS of ₹7 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.088%.
Which hedge fund is a major shareholder of Jupiter Life Line Hospitals Ltd.?
Currently, no hedge funds are holding shares in IN:JLHL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Jupiter Life Line Hospitals Ltd.
Jupiter Life Line Hospitals Ltd. (JLHL) is a healthcare organization based in India that operates a network of multi-specialty hospitals, providing comprehensive medical services across various sectors including cardiology, oncology, neurology, orthopedics, and critical care. The company is dedicated to delivering high-quality healthcare solutions through advanced medical technology and expert clinical staff, focusing on patient-centric care and innovative treatment options.
Technical Analysis
Aster DM Healthcare Ltd.
―
Fortis Healthcare Ltd.
―
Krishna Institute of Medical Sciences Limited
―
Global Health Limited
―
Narayana Hrudayalaya Ltd.
―